MedPath
HSA Approval

ISOCAINE (MEPIVACAINE HCL) INJECTION 3%

SIN14649P

ISOCAINE (MEPIVACAINE HCL) INJECTION 3%

ISOCAINE (MEPIVACAINE HCL) INJECTION 3%

October 24, 2014

N.K. LUCK (S) PTE LTD

N.K. LUCK (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantN.K. LUCK (S) PTE LTD
Licence HolderN.K. LUCK (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

SUBCUTANEOUS

Medical Information

N01BB03

mepivacaine

Manufacturer Information

n.k. luck (s) pte ltd

Novocol Pharmaceutical of Canada, Inc.

Active Ingredients

Mepivacaine HCl

30 mg/mL

Mepivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ISOCAINE (MEPIVACAINE HCL) INJECTION 3% - HSA Approval | MedPath